{"address1": "171 Oyster Point Boulevard", "address2": "Suite 400", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 489 9000", "website": "https://www.surrozen.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Surrozen, Inc., a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043, a hepatocyte-specific R-spondin mimetic bispecific fusion protein, which is in Phase 1b clinical trial for the treatment of severe liver diseases, including alcohol-associated hepatitis. The company develops SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies. Surrozen, Inc. is based in South San Francisco, California.", "fullTimeEmployees": 42, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig C. Parker M.B.A.", "age": 62, "title": "CEO, President & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 825320, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles  Williams", "age": 44, "title": "CFO, COO & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 611028, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Li  Yang Ph.D.", "age": 55, "title": "Executive Vice President of Research", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 535463, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. K. Christopher  Garcia Ph.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roeland  Nusse Ph.D.", "age": 74, "title": "Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1950, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Calvin  Kuo M.D., Ph.D.", "title": "Co-Founder & Member of Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Esther  Jhun", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.025, "open": 0.0252, "dayLow": 0.03, "dayHigh": 0.03, "regularMarketPreviousClose": 0.025, "regularMarketOpen": 0.0252, "regularMarketDayLow": 0.03, "regularMarketDayHigh": 0.03, "beta": 0.737, "volume": 4722, "regularMarketVolume": 4722, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.03, "fiftyTwoWeekHigh": 0.03, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 219491, "bookValue": 1.744, "priceToBook": 0.017201835, "netIncomeToCommon": -44438000, "trailingEps": -5.695, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.03, "recommendationKey": "none", "totalCash": 31012000, "totalCashPerShare": 9.543, "ebitda": -25060000, "totalDebt": 1527000, "quickRatio": 7.06, "currentRatio": 7.4, "totalRevenue": 10000000, "debtToEquity": 26.945, "revenuePerShare": 3.804, "returnOnAssets": -0.32645, "returnOnEquity": -1.73593, "grossProfits": -11877000, "freeCashflow": -19690376, "operatingCashflow": -28420000, "grossMargins": -1.1876999, "ebitdaMargins": -2.506, "operatingMargins": 0.1232, "financialCurrency": "USD", "symbol": "SRZNW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Surrozen, Inc. Warrant", "longName": "Surrozen, Inc.", "corporateActions": [], "regularMarketTime": 1743451200, "exchange": "NCM", "messageBoardId": "finmb_401948183", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 19.999996, "regularMarketPrice": 0.03, "marketState": "PRE", "fullExchangeName": "NasdaqCM", "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.03 - 0.03", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "epsTrailingTwelveMonths": -5.695, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-12", "prevName": "Consonance-HFW Acquisition Corp.", "nameChangeDate": "2025-04-01", "cryptoTradeable": false, "hasPrePostMarketData": true, "regularMarketChange": 0.004999999, "regularMarketDayRange": "0.03 - 0.03", "displayName": "Surrozen", "trailingPegRatio": null}